Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-31 @ 8:37 AM
Study NCT ID:
NCT01707992
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2012-09-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Sclerosis | View |
Keywords: